Literature DB >> 20541035

Tenascin-W: an extracellular matrix protein associated with osteogenesis and cancer.

Enrico Martina1, Ruth Chiquet-Ehrismann, Florence Brellier.   

Abstract

Tenascin-W was the last member of a family of four large extracellular matrix glycoproteins to be discovered. The original member of the tenascin family, tenascin-C, has been widely studied due to its association with asthma, fibrosis, infection, inflammation and cancer. Recent studies report multiple common features between tenascin-W and tenascin-C in terms of structure, expression and function, especially in the context of tumorigenesis. Furthermore, specific functions for tenascin-W in osteogenesis have been revealed. This review presents an update on our current knowledge concerning tenascin-W and discusses potential medical applications of this cancer-enriched extracellular matrix protein. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20541035     DOI: 10.1016/j.biocel.2010.06.004

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  13 in total

Review 1.  Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization.

Authors:  Andrew J Sawyer; Themis R Kyriakides
Journal:  Adv Drug Deliv Rev       Date:  2016-01-04       Impact factor: 15.470

Review 2.  Tenascins and the importance of adhesion modulation.

Authors:  Ruth Chiquet-Ehrismann; Richard P Tucker
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-05-01       Impact factor: 10.005

3.  The expression of tenascin-C and tenascin-W in human ossicles.

Authors:  Richard P Tucker; Cathryn A Peterson; Ismail Hendaoui; Sandrine Bichet; Ruth Chiquet-Ehrismann
Journal:  J Anat       Date:  2016-05-27       Impact factor: 2.610

Review 4.  Role of tenascins in the ECM of gliomas.

Authors:  Nicole Brösicke; Andreas Faissner
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

5.  Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation.

Authors:  Stephan Niland; Johannes A Eble
Journal:  J Oncol       Date:  2011-09-18       Impact factor: 4.375

Review 6.  How do tenascins influence the birth and life of a malignant cell?

Authors:  Florence Brellier; Ruth Chiquet-Ehrismann
Journal:  J Cell Mol Med       Date:  2012-01       Impact factor: 5.310

Review 7.  Transcriptional regulation of tenascin genes.

Authors:  Francesca Chiovaro; Ruth Chiquet-Ehrismann; Matthias Chiquet
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

8.  Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors.

Authors:  Florence Brellier; Enrico Martina; Martin Degen; Nathalie Heuzé-Vourc'h; Agnès Petit; Thomas Kryza; Yves Courty; Luigi Terracciano; Christian Ruiz; Ruth Chiquet-Ehrismann
Journal:  BMC Clin Pathol       Date:  2012-09-04

9.  Mesenchymal Remodeling during Palatal Shelf Elevation Revealed by Extracellular Matrix and F-Actin Expression Patterns.

Authors:  Matthias Chiquet; Susan Blumer; Manuela Angelini; Thimios A Mitsiadis; Christos Katsaros
Journal:  Front Physiol       Date:  2016-09-07       Impact factor: 4.566

Review 10.  Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy.

Authors:  Ana Cavaco; Maryam Rezaei; Stephan Niland; Johannes A Eble
Journal:  Int J Mol Sci       Date:  2017-11-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.